Related Experiment Video
Updated: Jun 11, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Runx regulation of sphingolipid metabolism and survival signaling
Anna Kilbey1, Anne Terry, Alma Jenkins
1Molecular Oncology Laboratory, Faculty of Veterinary Medicine, Institute of Comparative Medicine, University of Glasgow, Glasgow, United Kingdom. A.Kilbey@vet.gla.ac.uk
Abstract:
The Runx genes (Runx1, 2, and 3) regulate cell fate in development and can operate as either oncogenes or tumor suppressors in cancer. The oncogenic potential of ectopic Runx expression has been shown in transgenic mice that develop lymphoma in potent synergy with overexpressed Myc, and in established fibroblasts that display altered morphology and increased tumorigenicity. Candidate oncogenic functions of overexpressed Runx genes include resistance to apoptosis in response to intrinsic and extrinsic stresses. In a search for gene targets responsible for this aspect of Runx phenotype, we have identified three key enzymes in sphingolipid metabolism (Sgpp1, Ugcg, and St3gal5/Siat9) as direct targets for Runx transcriptional regulation in a manner consistent with survival and apoptosis resistance. Consistent with these changes in gene expression, mass spectrometric analysis showed that ectopic Runx reduces intracellular long-chain ceramides in NIH3T3 fibroblasts and elevated extracellular sphingosine 1 phosphate. Runx expression also opposed the activation of c-Jun-NH(2)-kinase and p38(MAPK), key mediators of ceramide-induced death, and suppressed the onset of apoptosis in response to exogenous tumor necrosis factor alpha. The survival advantage conferred by ectopic Runx could be partially recapitulated by exogenous sphingosine 1 phosphate and was accompanied by reduced phosphorylation of p38(MAPK). These results reveal a novel link between transcription factor oncogenes and lipid signaling pathways involved in cancer cell survival and chemoresistance.
Insights
Runx genes regulate cell fate and cancer. Ectopic Runx expression promotes cancer cell survival by altering sphingolipid metabolism and resisting apoptosis, revealing a link between transcription factors and lipid signaling in cancer.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- Runx genes (Runx1, 2, and 3) are critical for cell fate during development.
- In cancer, Runx genes can function as oncogenes or tumor suppressors.
- Ectopic Runx expression is linked to oncogenic functions, including resistance to apoptosis.
Purpose of the Study:
- To identify gene targets responsible for the apoptosis-resistant phenotype associated with ectopic Runx expression.
- To investigate the role of sphingolipid metabolism in Runx-mediated cancer cell survival.
Main Methods:
- Identified direct transcriptional targets of Runx in sphingolipid metabolism (Sgpp1, Ugcg, St3gal5/Siat9).
- Utilized mass spectrometry to analyze changes in ceramide and sphingosine 1 phosphate levels.
- Assessed the impact of Runx expression on apoptosis signaling pathways (c-Jun-NH(2)-kinase and p38(MAPK)).
Main Results:
- Ectopic Runx directly targets key sphingolipid metabolism enzymes, altering lipid profiles.
- Runx expression reduced intracellular long-chain ceramides and increased extracellular sphingosine 1 phosphate.
- Runx opposed c-Jun-NH(2)-kinase and p38(MAPK) activation, suppressing apoptosis induced by TNF-alpha.
Conclusions:
- Runx transcription factors directly regulate sphingolipid metabolism enzymes.
- This regulation contributes to cancer cell survival and chemoresistance by modulating lipid signaling.
- Reveals a novel connection between oncogenic transcription factors and lipid pathways in cancer.
Related Concept Videos
Regulation of the Unfolded Protein Response
Regulation of Nuclear Protein Sorting
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

